Moderna Vaccine Covid-19 produces a strong antibody response in the baby model, finding a study
A new study conducted by a group of scientists has found that the Covid-19 Moderna vaccine offers a powerful neutralization antibody response to the virus on the rhesus baby apes without side effects.
A strong powerful immune response caused by the vaccine in 16 babies Rhesus ape survived for 22 weeks, the results published in the Immunology Science said, according to the Indian Express report.
Track this direct blog for the latest updates about the Coronavirus pandemic
To evaluate the vaccination of SARS-COV-2 baby, the researchers mounced two groups from 8 Rhesus Babies at the age of 2.2 months and 4 weeks later.
Each animal accepts the praclinist version of the Moderna MRNA vaccine or a protein-based vaccine developed by the National Institute of Allergy and Niabs (Niaid), the US, the report said.
“The effective antibody level we observe is comparable to what has been seen in adult apes, even though the dose is 30 micrograms instead of adult micrograms,” said one of the writers of Kristina de Paris, PhD, Professor of Microbiology and Immunology at North Carolina University.
Researchers are conducting further challenge studies to better understand the potential protection lasts a long time from the vaccine.
The authors say that vaccines for small children are likely to be important and safe tools to reduce pandemic.
Modernum last month said that the Covid-19 vaccine was highly protected children as young as 12.
The company has also submitted an application with US food and medicine administration, European and Canadian regulators for emergency use permits for its vaccines to be given to adolescents.
The company had previously announced the results of the 3,700 12-year-old trial which found a two-dose regimen safe and very effective.
Both Pfizer and Moderna have begun to test the younger children, since the age of 11 ages until the baby is 6 months old.
